Expression of TNFRSF1B was observed to correlate with CD3E expression (a marker for T cell infiltration of tumors) [30] for multiple tumor types, including bladder urothelial carcinoma, breast invasive carcinoma, head and neck squamous cell carcinoma, kidney carcinoma, lung squamous cell carcinoma, prostate adenocarcinoma, melanoma, and uterine corpus endometrial carcinoma (Supplementary Figure S7). The gene discussed is CD3E; the disease is neoplasm.